All Stories

  1. A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses
  2. USP16 is an ISG15 cross-reactive deubiquitinase that targets pro-ISG15 and ISGylated proteins involved in metabolism
  3. Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms
  4. A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants